The Effect of Dexmedetomidine on Postoperative Analgesia

Phase 4

Completed

• Conditions: Colon Cancer, Rectal Cancer
• Interventions: Drug: Fentanyl; Drug: Dexmedetomidine

• Registration Number: NCT01373021
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The purpose of this study is to determine whether additional Dexmedetomidine to patient controlled analgesia can reduce fentanyl consumption.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06
• Study First Submitted: 2011-06-13
• Study First Submitted QC: 2011-06-13
• Study First Posted: 2011-06-14
• Primary Completion: 2012-02
• Study Completion: 2012-02
• Status Verified: 2012-03
• Last Update Submitted: 2012-03-06
• Last Update Posted: 2012-03-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 95

Inclusion Criteria

• Elective surgery for colon cancer

Exclusion Criteria

• Liver disease
• Kidney disease
• Allergy for study drugs
• Inability to receive patient controlled analgesia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
F	Fentanyl	Fentanyl+Normal saline
D	Dexmedetomidine	Fentanyl+Dexmedetomidine

Primary Outcome Measures

Name	Time	Method
total amount of administered fentanyl	during first 24 hours after surgery

Trial Locations

Locations (1)

Seoul national university hospital; 🇰🇷 Seoul, Korea, Republic of